Pharmaceutical Technology's Equipment and Machinery Spending Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology's Equipment and Machinery Spending Survey
The pharmaceutical industry plans moderate increases in spending for equipment and machinery in 2007 as expenditures hold steady.

Pharmaceutical Technology


The results of Pharmaceutical Technology's Equipment and Machinery Spending Survey show that spending on pharmaceutical equipment and equipment is holding steady for 2007, with moderate increases planned for this year. The survey gauges spending levels and factors influencing spending for machinery and equipment used in pharmaceutical manufacturing.

For purposes of the survey, machinery and equipment refers to equipment and machinery for solid-dosage, aseptic, sterile, parenteral, active pharmaceutical ingredient manufacturing, quality control and assurance (including analytical instrumentation and laboratory equipment), process control and automation, pharmaceutical packaging, and environmental control.


Respondents profile
The survey (see sidebar, "Respondents' profile") was targeted at individuals with responsibility for purchasing, authorizing purchasing, or reviewing purchasing for equipment and machinery for a pharmaceutical company.

Spending increases slow

The survey asked respondents whether their companies plan to increase spending on machinery and equipment in 2007 and whether they increased spending in 2006 and 2005 (see Figure 1). In 2006 and 2005, the number of respondents increasing spending was fairly consistent: 59.2% in 2006 and 63.3% in 2005. For 2007, however, only 40.8% of respondents said they plan to increase spending, and 26.5% do not plan to increase spending in 2007.


Figure 1: (see pie charts on this page): Spending increases on pharmaceutical machinery and equipment: planned for 2007, in 2006, and in 2005.























Levels of spending


Figure 2
To gauge the level of spending on equipment and machinery, the survey asked participants to estimate their companies' spending as a percentage of overall revenues (see Figure 2) and in absolute amounts (see Figure 3).

In estimating spending for 2007, 29.8% of respondents say their companies plan to spend between 2.1–4% of their overall revenues on equipment and machinery and 25.5% plan to spend 0.1–2% of their overall revenues on equipment and machinery (see Figure 2). In 2006, only 16.3% of respondents said their companies spent 2.1–4% of their overall revenues on equipment and machinery.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
75%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here